Position in MRK
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$19,955,022
+$19,955,022 QoQ
Shares Held
155,292
Ownership
0.006%
of shares outstanding
% of Portfolio
0.79%
of 13F equity value
Holder Rank
#521
of 3,769 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 36%
Shared 0%
None 64%
Common Shares in MRK Over Time
Shares Held
Position Value (USD)
Derivatives in MRK
reported options exposure · as of Mar 31, 2026CallValue
$0
CallShares
0
PutValue
$18,672,255
PutShares
155,227
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026LOGAN CAPITAL MANAGEMENT INC holds $143,017,458 across 13 Drug Manufacturers - General names. MRK ranks #2 (14.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
27,791 | $33,333,361 | |
| 2 | MRK |
Merck & Co., Inc.
This page
|
155,292 | $19,955,022 | |
| 3 | ABBV |
AbbVie Inc.
|
77,182 | $19,422,078 | |
| 4 | JNJ |
Johnson & Johnson
|
62,551 | $15,886,077 | |
| 5 | NVS |
Novartis AG
|
73,584 | $11,532,084 | |
| 6 | SNY |
Sanofi
|
258,642 | $11,033,667 | |
| 7 | PFE |
Pfizer Inc
|
442,396 | $10,652,895 | |
| 8 | GSK |
GSK plc
|
141,076 | $7,395,203 |
All Filings in MRK
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $19,955,022 | 155,292 | Shares | Other | 2026-08-14 | |
| 2026-03-31 | $18,672,255 | 155,227 | Put | Other | 2026-05-08 | |
| 2025-12-31 | $16,327,299 | 155,114 | Shares | Other | 2026-02-12 | |
| 2025-09-30 | $13,329,510 | 158,817 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $12,560,475 | 158,672 | Shares | Other | 2025-08-01 | |
| 2025-03-31 | $14,942,347 | 166,470 | Shares | Other | 2025-05-16 | |
| 2024-12-31 | $16,286,865 | 163,720 | Shares | Other | 2025-02-14 | |
| 2024-09-30 | $18,615,663 | 163,928 | Shares | Sole | 2024-12-06 | |
| 2024-06-30 | $20,332,416 | 164,236 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $21,675,822 | 164,273 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $17,999,856 | 165,106 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $16,994,162 | 165,072 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $19,052,850 | 165,117 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $18,124,599 | 170,360 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $19,056,993 | 171,762 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $11,188,623 | 129,919 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $11,797,124 | 129,397 | Shares | Sole | 2022-08-11 | |
| 2022-03-31 | $10,520,942 | 128,226 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $9,808,157 | 127,977 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $9,927,889 | 132,178 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $10,125,187 | 130,194 | Shares | Other | 2021-08-17 | |
| 2021-03-31 | $10,178,737 | 132,037 | Shares | Sole | 2021-05-14 | |
| 2020-12-31 | $10,820,417 | 132,279 | Shares | Sole | 2021-02-12 | |
| 2020-09-30 | $11,098,549 | 133,798 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $10,406,070 | 134,567 | Shares | Sole | 2020-08-14 | |
| 2020-03-31 | $10,304,184 | 133,925 | Shares | Sole | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||